Case Western Reserve Lands NIDA Grant of up to $3M | GenomeWeb

NEW YORK (GenomeWeb News) — Case Western Reserve University has received a grant worth up to $3 million from the National Institute of Drug Abuse to conduct proteomic studies of Hepatitis C and HIV infections, Case's School of Medicine said today.

The three-year NIDA grant will fund development of proteomic and epigenetic markers for chronic immune activation during HIV disease and studies of the effects of current and prior drug use and HCV infection on disease progression and therapy.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: cell-free DNA from tumors is shorter than DNA from healthy cells, type 2 diabetes-related loci, and more.

Genetic analysis confirms that blood found on leaves collected near Marche-les-Dames some 80 years ago belongs to King Albert I of Belgium.

Researchers in the US begin to seek participants for the 1 million-person precision medicine cohort, the New York Times reports.

A new report indicates that women are underrepresented among US patent holders.